Home » Newsletters » BioWorld Science

BioWorld Science

April 26, 2005

View Archived Issues

Similar analgesic effects found for M6G and morphine sulfate after major surgery

Rimonabant reduces the prevalence of metabolic syndrome among obese patients

Researchers find a lower incidence of AMD in subjects taking cholesterol-lowering drugs

Protective effects of STAZN following hemorrhagic shock

PRO-001 a novel therapeutic strategy for multiple myeloma

Myocardial protective properties of H-89

Baraclude available in U.S.

AEterna Zentaris establishes collaboration with Julius Maximilians University

Positive findings for low-dose doxepin in elderly patients with insomnia

Series C financing to advance Molecular Insight's BMIPP into phase III

AFG-495, a cathepsin K inhibitor, evaluated for bone metastases

Thalidomide analogues show antiangiogenic actions in vitro

Titanocene derivative tested for anticancer activity

EP-1572 reported to induce growth hormone secretion in healthy volunteers

Update on the effects and safety of DAC:GLP-1 in type 2 diabetes

EMEA completes review of antidepressants in children and adolescents

KOS-1584 shows promise as a novel antitumor drug

First evidence for the benefits of statin therapy in PCOS

New formulations of dapsone for cerebral infarction

Recent patents cover novel therapeutic agents for vascular disorders

CHMP recommends lifting marketing restrictions on Serdolect

Provensis plans to submit study protocol for Varisolve

Risperdal approved in Canada for acute treatment of manic symptoms

Bar-Ilan University describes therapeutic agents for use in male contraception

Kyorin to acquire Toyo Pharmar stock

Prodrugs for treating alcoholism and opioid dependency developed at the University of Kentucky

Dual-targeting estrone sulfatase inhibitor/SERM for breast cancer therapy

New agents for thrombocytopenia from Yamanouchi R&D

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...